HealO Medical - Healing Faster For Less™

HealO Medical, LLC™, is a US-headquartered medical device company with transformational technology in wound therapeutics.

Our mission is to provide the most advanced wound therapies for hyper-accelerated healing without painful dressing changes.

Founded by Dr. Edward Lin, a physician, scientist and inventor, HealO’s advanced wound care system, O-ACE-Sys™ has won national and international awards, the support of preeminent wound care experts at renowned US medical centers, as well as a 10 million RMB Leading Pioneer Award from China.

In the US, HealO’s O-ACE-Sys™ technology will impact and shape the way $25 billion is spent annually to treat 6 million chronic wounds. Under Obamacare and the Affordable Care Act, the pressure is greater than ever to provide the most efficacious and cost-effective therapy. HealO’s O-ACE-Sys is well positioned to score high on four out of the five quality metrics. By providing faster healing at a lower cost, HealO will likely enjoy rapid market acceptance and penetration.

See sample chronic wound photos (Warning: graphic images)

The wound care market is undergoing robust and steady growth due to the convergence of five aggravating major epidemiologic factors:
  1. Number of diabetics has more than doubled: Worldwide incidence of diabetes increased from 171 million in 2000 to 366 million today (International Diabetes Federation, 9/14/11).

  2. Aging population compounds wound care burden with more peripheral vascular diseases.
    • 78 million aging baby boomers in the US
    • 300 million over age 65 in China

  3. A “supersize” obesity epidemic will result in even more diabetes and vascular diseases.
    Based on current trends, 50% of adults in US will be obese by 2030 (Lancet, August 23, 2011);
    In 2008, 205 million men and 297 million women globally were obese. An additional 1.5 billion adults were overweight.

  4. Rising incidence of drug-resistant microbes = persistent infections that will be harder than ever to treat.
  5. graph1

  6. A virtually dry antibiotic pipeline = bleak outlook for infected wounds and continued slow-healing.


HealO plans to introduce innovative and cost effective wound healing solutions for the benefit of patients, healthcare professionals and our investors.